Constellation Pharmaceuticals, Inc.
THERAPEUTIC COMPOUNDS AND USES THEREOF

Last updated:

Abstract:

The present invention relates to compounds of formula (I) and formula (II): ##STR00001## and to salts thereof, wherein R--R.sup.4 of formula (I) and R.sup.5-R.sup.6 of formula (II) have any of the values defined herein, and compositions and uses thereof. The compounds are useful as inhibitors of CBP and/or EP300. Also included are pharmaceutical compositions comprising a compound of formula (I) of formula (II), or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various CBP and/or EP300-mediated disorders.

Status:
Application
Type:

Utility

Filling date:

28 May 2020

Issue date:

24 Dec 2020